Yes tr>
2019 Conference Agenda
 
Wednesday Thursday Friday
 
Tuesday, May 28, 2019
6:00 - 8:00 pm "Welcome to Boston"- COCKTAIL RECEPTION
 
 
Wednesday, May 29, 2019
7:15 - 8:30 am BREAKFAST
8:30 - 9:00 am Welcome | Day One Introductions and Announcements
  2019 Boston Conference Chairman: Justin Renz, President & CFO, Correvio Pharmaceuticals, Inc.
9:00 - 10:15 am KEYNOTE PRESENTATION: "Government and Policy"
    Speakers:
Panelists:
Jon Chesto, Reporter, Boston Globe. Business
TBD
10:15 -10:30 am Break
10:30 -12:00 pm KEYNOTE SPEAKER: Mike Eruzione, Captain, 1980 US Gold Medal Olympic Team, "Miracle on Ice"
   
12:00 - 1:15 pm LUNCH
1:15 - 2:15 pm Technical Accounting Update - Ernst & Young LLP
  Update on the latest accounting developments that are expected to impact bioscience companies. EY will share their insights on how the matters are being interpreted, what bioscience companies should be focused on, and how the various regulatory bodies view these areas.
    Moderator: Michael Formolo, Partner, Ernst & Young, LLP
2:15 - 3:15 pm PANEL PRESENTATION: CFO ROUNDTABLE
   
    Moderator:
Panelists:
Iain Brown, Senior Vice President of Finance, Chief Accounting Officer, Alkermes Inc.
Lorence Kim
, Chief Financial Officer, Modera Therapeutics
Jim Frates,
Chief Financial Officer, Alkermes, Inc.
TBD
3:15 -3:30 am Break
3:30 - 4:30 pm KEYNOTE PRESENTATION: Kevin Gillis, "Private to Public Life Style Transition"
    Moderator:
Panelists:
Kevin Gillis, Partner, Chief Financial Officer, Third Rock Ventures
Mike Landsittel
, Chief Financial Officer, Blueprint Medicines
Yasir Al-Wakeel,
Chief Financial Officer, Neon Therapeutics, Inc.
Cindy Driscoll,
Vice President, Finance, Magenta Therapeutics, Inc.
4:30 - 5:30 pm "Cybersecurity & Crypto-currency"
   
    Moderator:
Panelists:
Kristin Kraeger, Managing Director, AON
Kevin Jacobsen, Executive Director, Advisory Services, Cybersecurity & Insider Risk
Jim Trainor, Senior Vice President, AON, former Assistant Director, Cyber Division, Federal Bureau of Investigation
Mary Rosendahl, eChannel Product Manager, Bank of America Merrill Lynch
5:40 pm Evening Social Event and Networking - Cocktail Hour, Walk to Fenway Park, Boston Red Sox vs. Cleveland Indians, game starts at 7:10 pm - Game limited to first 120 sign-ups
       
       
Thursday, May 30
7:15 - 8:30 am BREAKFAST
8:30 - 9:00 am Welcome | Day Two Introductions and Announcements
  2020 San Diego Conference Chairman:  
9:00 - 10:15 am KEYNOTE SPEAKER: Robert Coughlin, President & CEO, Massachusetts Biotech Counsel, "My Journey as Father, Patient Advocate and CEO of MassBio"
   
10:15 - 10:30 am Break
10:30 - 11:30 am PANEL PRESENTATION: "A New Generation of CFOs"
  This conversation will span diversity of experience (sectors, foundational training, etc.) we are seeing across the industry, primarily driven by market demand and a supply shortage in talent. We also have quite a bit of interesting data to share regarding market dynamics.
    Presenters: Cissy Young, Managing Director, Russell Reynolds Associates
Rose Mistri-Somers, Consultant, Russell Reynolds Associates
Hunter Smith, Chief Financial Officer, Rhythm Pharmaceuticals, Inc.
David Spellman, Chief Financial Officer, Mersana Therapeutics
Allan Reine,
Chief Financial Officer, Pieris Pharmaceuticals
Tommy Leggett,
Chief Financial Officer, Axcella
11:30 - 12:15 pm KEYNOTE PRESENTATION: "Women in Leadership"
   
    Moderator:
Panelists:
Sarah Larson, Partner, Third Rock Ventures
Kim Drapkin, Chief Financial Officer, Jounce Therapeutics, Inc.
Kimi Iguchi, Chief Financial Officer, Sage Therapeutics, Inc.
Pam Kelleher, Partner, Ernst & Young, LLP
12:15 - 1:15 pm LUNCH [Regional Coordinators' Meeting]
1:15 - 2:15 pm KEYNOTE SPEAKER: Solomon Wilcots, NFL Broadcaster/Leader, Russo Partners' Sports-Health Alliance, "How Preparation Eliminates Pressure"
  Solomon will give insight on how to make winning decisions under pressure
  Short Break to Change Rooms
2:15 - 3:15 pm PANEL PRESENTATIONS - Select One
  A. Compensation
An interactive session organized by AON that will delve into the latest news to come out of ISS, the SEC and others, as well as what Radford has observed this year in interactions with board, management and proxy advisors. The presenters will discuss corporate guidelines and regulatory development in compensation.
    Presenters: TBD
  B. XBRL Use This presentation, overseen by Toppan Merrill, will cover how the use of XBRL is reaching a tipping point and revolutionizing how the SEC and investing community is benefiting by its use. Participants will  learn how users of this data, especially the SEC, can effectively compare filings for abnormalities, patterns, outliers, or other trends that could indicate misconduct, and give the SEC insight into issues of which a Registrant may not even be aware.
    Presenters: Mike Schlanger, Vice President, Solution Sales, Toppan Merrill
Mike Willis, Assistant Director, Office of Structured Disclosure, Division of Economics and Risk Analysis, U.S Securities and Exchange Commission
Christine Tan,
Ph.D., Chief Research Officer & Co-founder, idaciti, Inc.
  C. Financial and Resource Management - TARGETED Reporting and Dashboards - Why It Matters Timely delivery of the right information to the right people can be daunting. Join us to discuss "Targeted, Role Based Reporting and Dashboards." This panel discussion will address how you can finally empower your business partners with meaningful financial data without breaking the finance organization.  Due to the automation that makes this possible, you can now expand the definition of "stakeholder," ignore the complex legal structure and just get on with being the strategic partner Finance is supposed to be.
    Presenters: Joyce Bellomo, Chief Financial Officer, Chief Business Officer, R&D Logic, Inc.
TBD
  Short Break to Change Rooms
3:15 - 4:15 pm COMPANY ROUNDTABLES - Select One
  These company roundtables will be facilitated by Pepper Hamilton, LLP along with carefully selected CFOs from each of the company stages with the aim of providing a forum for thoughtful discussion of the issues relevant to each.
  Early Stage Companies    
  Late Stage Companies Moderated by: Pepper Hamilton, LLP
  Commercialized Companies    
4:15 - 4:30 pm Break
4:30 -5:30 pm PANEL PRESENTATION - "Making Optimal R&D Investment Decisions - EY Parthenon"
    Moderator:
Panelists:
Jeff Stoll - Partner, Life Sciences, EY Parthenon
TBD
  15 Minute Break Before Evening Special Event
5:45 pm Thursday Evening Special Event - Buses to leave at 5:45 pm
 
Friday, May 31, 2019
7:15 - 8:45 am BREAKFAST
8:45 - 9:00 am Welcome | Day Three Introductions and Announcements
2019 Boston Conference Chairman: Justin Renz, President & CFO, Correvio Pharmaceuticals, Inc.
9:00 - 10:15 am KEYNOTE SPEAKER: Joseph Quinlan, Managing Director & Chief Market Strategist, US Trust, Bank of America, Private Wealth Management
   
10:15 - 11:15 am PANEL PRESENTATION: "Beyond the C-Suite"
  This session will address how to prepare CFOs to move beyond the finance function and into broader roles in addition to the Boardroom. Our panelists will be a number of individuals who have successfully transitioned into CBO/COO/CEO roles from Finance, in addition to sitting CFOs who serve on Boards today.
    Presenters:

Panelists:
Cissy Young, Managing Director, Russell Reynolds Associates
Rose Mistri-Somers, Consultant, Russell Reynolds Associates
TBD
11:15 am Conference Concludes
       
       
Back to Top